drugset / Trial / NCT06020781

Efficacy and Safety of Dexmedetomidine to Bupivacaine in Supraclavicular Brachial Plexus Block

NCT06020781 ↗

Completed 75 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

The study aims to evaluate the analgesic efficacy and safety of addition of 1µg/kg dexmedetomidine to 20ml bupivacaine compared to 20ml and 30ml bupivacaine without additives in ultrasound-guided supraclavicular brachial plexus block for anesthesia.

Timeline

Start
2023-10-09
Primary completion
2024-03-11
Completion
2024-03-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Bupivacaine Other / unclassified 30 ml Other
Subject Dexmedetomidine Other / unclassified 1 ug/kg Other

Indications

No indication recorded.